MORGAN STANLEY - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$10,897
-67.0%
62,273
-18.4%
0.00%
Q3 2022$33,000
-64.9%
76,330
-31.3%
0.00%
Q2 2022$94,000
-93.7%
111,100
-59.3%
0.00%
Q1 2022$1,502,000
-42.1%
272,737
+1.7%
0.00%
Q4 2021$2,595,000
+16.3%
268,082
+114.9%
0.00%
Q3 2021$2,231,000
-25.6%
124,723
+1.5%
0.00%
Q2 2021$2,999,000
+194.9%
122,862
+220.3%
0.00%
Q1 2021$1,017,000
+142.7%
38,356
-30.6%
0.00%
Q4 2020$419,000
+235.2%
55,299
+121.8%
0.00%
Q3 2020$125,000
-90.5%
24,928
-88.7%
0.00%
Q2 2020$1,317,000
+382.4%
220,195
+257.6%
0.00%
Q1 2020$273,000
-72.5%
61,574
-40.9%
0.00%
Q4 2019$991,000
-8.4%
104,261
-24.3%
0.00%
Q3 2019$1,082,000
-9.7%
137,782
+80.9%
0.00%
Q2 2019$1,198,000
-21.4%
76,145
-9.6%
0.00%
Q1 2019$1,525,000
+62.4%
84,247
+44.4%
0.00%
Q4 2018$939,000
-30.9%
58,359
+3.1%
0.00%
Q3 2018$1,359,00056,6090.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,296,526$290,671,0005.29%
HARBOURVEST PARTNERS LLC 986,878$7,490,0002.93%
Abbot Financial Management, Inc. 537,000$4,076,0002.35%
Artal Group S.A. 3,778,913$28,682,0000.62%
HITE Hedge Asset Management LLC 88,740$674,0000.16%
Virtus ETF Advisers LLC 33,793$256,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,909$2,997,0000.03%
Baillie Gifford 4,710,061$35,749,0000.02%
Caption Management, LLC 86,000$652,0000.02%
Blueshift Asset Management, LLC 14,626$111,0000.01%
View complete list of RUBIUS THERAPEUTICS INC shareholders